Therapy for Stage IV NSCLC With Driver Altera...

Drs. Tina Lockwood and Stacy Gray share the newly released evidence-based guideline on circulating tumor DNA (ctDNA) testing from ASCO. They highlight recommendations on when ctDNA testing should be offered—including scenarios where tissue biopsies are challenging, unsafe, or una ...  Show more

Dr. Joshua Reuss returns to the podcast to discuss the update to the living guideline on stage IV NSCLC with driver alterations. The conversation focuses on new cancer treatment strategies for patients with advanced NSCLC and EGFR mutations, including classical EGFR alterations ( ...  Show more

Fill up with delicious practice-changing knowledge food from #SGIM22 as The Curbsiders team discusses breast cancer survivorship, sexual dysfunction, How climate change will affect health, Are PT consults necessary in the hospital?, Do we need antibiotics for aspiration events?, ...  Show more

FOURIER authors' response, a possible practice-changing paper in electrophysiology, and the ATLAS and CAPLA trials are the topics John Mandrola, MD, discusses in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a p ...

Quelle voie d’abord privilégier ? Faut-il faire une exérèse de l’uretère distal ?Faut-il faire une ligature première de l’uretère ?Faut-il faire un curage ganglionnaire ? Faut-il faire une IPOP ?Le Dr Xylinas (CHU Bichat, Paris) répond à toutes vos questions ! L’orateur n’a pas r ...  Show more

Carla Wrenn, naturopath and educator, provides us with her insights into the important role the integrative practitioner may play in holistically supporting the oncology patient in our latest podcast. Having worked with our ambassador, Dr. Michelle Woolhouse in a collaborat ...  Show more